Brandon May

Researchers sought to investigate the association between sleep-disordered breathing and sleep-related hypoxia with SARS-CoV-2 infection and COVID-19 outcomes.

People with diabetes are at a higher risk of experiencing poor outcomes after contracting COVID-19, including hospitalization and death. Researchers expanded on a previous analysis to identify risk factors for short-term adverse outcomes among veterans with diabetes and COVID-19.

Investigators conducted a review to assess the role of glucagon-like peptide-1 receptor agonists in the treatment of NAFLD and NASH.

Researchers assessed the sex-specific association between self-reported sleep duration and mortality in an East Asian population.

A new algorithm offers guidance on when to start and stop noninvasive respiratory therapies for COVID-19.

A team of researchers investigated the effect of interventions to overcome therapeutic inertia regarding glycemic control in patients with type 2 diabetes.

Investigators assessed the effectiveness of Hemospray for the management of GI bleeding.

Investigators compared bariatric surgery with a community weight management intervention in ability to reduce intracranial pressure among patients with idiopathic intracranial hypertension.

Investigators examined the clinical characteristics of patients with IBD and VTE and identified risk factors associated with VTE occurrence.

Investigators assessed the effectiveness of treatment with methylprednisolone vs dexamethasone for hospitalized COVID-19 patients with hypoxia.